COMP <GO>
MEOH vs CBT // FORWARD P/E MULTIPLE
Methanex Corporation (NASDAQ) VS. Cabot Corporation (NYSE) • 15-METRIC TALLY: MEOH 2
— CBT 1
■ METRIC PARITY
LAST: $71.57 (+14.04%) • MKT CAP: $4.86B
forward-pe
—
LAST: $74.43 (+0.79%) • MKT CAP: $3.81B
forward-pe
10.7x
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (MEOH VS. CBT)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | MEOH | CBT | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | — | 25.30% | — | TIE | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | — | 22.30% | — | TIE | /roic <GO> |
| EV/EBITDA & P/E Valuation | — | 5.2x | — | TIE | /valuation <GO> |
| Free Cash Flow Yield | — | 10.25% | — | TIE | /fcf-yield <GO> |
| Operating Margin | — | 16.70% | — | TIE | /operating-margins <GO> |
| Net Profit Margin | — | 8.90% | — | TIE | /net-margins <GO> |
| Revenue Growth (YoY) | — | -7.00% | — | TIE | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.00% | 2.52% | -2.52 | CBT | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | — | — | — | TIE | /balance-sheet <GO> |
| Piotroski F-Score Quality | — | 7/9 | — | TIE | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | — | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 50.0 | 40.6 | +9.40 | MEOH | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | — | — | — | TIE | /macro-sensitivity <GO> |
| Forward P/E Multiple ACTIVE | — | 10.7x | — | TIE | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $4.86B | $3.81B | $1.04B | MEOH | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | MEOH REV | CBT REV | MEOH GROSS % | CBT GROSS % | MEOH FCF | CBT FCF |
|---|---|---|---|---|---|---|
| FY 2025 | — | $3.71B | — | 25.3% | — | $391.0M |
| FY 2024 | — | $3.99B | — | 24.0% | — | $451.0M |
| FY 2023 | — | $3.93B | — | — | — | $595.0M |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
MEOH // BETA —
CBT // BETA —